Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Abnormal Proliferation02:23

Abnormal Proliferation

4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Bioinspired 0D mitochondrial bioenergetic actuators rewire cartilage progenitor cell metabolism for osteoarthritis remission.

Bioactive materials·2026
Same author

Targeting pathogenic VWF/ADAMTS13 dysregulation attenuates CTEPH progression.

bioRxiv : the preprint server for biology·2026
Same author

A physiology-informed microRNA framework for urothelial carcinoma in hemodialysis patients.

Renal failure·2026
Same author

Accurate focal-plane selection is crucial for artificial intelligence assessment of three-dimensional urine cytology specimens for bladder cancer screening and surveillance.

Cancer cytopathology·2026
Same author

Automatic beam angle optimization in brain tumor radiotherapy using deep reinforcement learning.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2026
Same author

Advances in Ammonium Ion Supercapacitors Based on Two-Dimensional Electrode Materials: A Comprehensive Review.

Chemical record (New York, N.Y.)·2026

相关实验视频

Updated: Sep 11, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

266

通过PRMT1介导的代谢重编程促进了白血病发生.

Hairui Su1, Yong Sun2,3, Han Guo4

  • 1Department of Biochemistry and Molecular Genetics, The University of Alabama at Birmingham, School of Medicine, Birmingham, United States.

eLife
|August 13, 2025
PubMed
概括

蛋白质氨酸甲基转移酶1 (PRMT1) 驱动急性巨核细胞白血病 (AMKL) 通过促进糖解和阻碍脂肪酸氧化. 抑制PRMT1或准葡萄糖代谢为这种癌症提供了治疗策略.

关键词:
CPT1A 一个问题.在PRMT1中,癌症生物学 癌症生物学细胞生物学 细胞生物学脂肪酸 脂肪酸 脂肪酸 脂肪酸葡萄糖溶解是什么这种白血病是白血病.线粒体中的线粒体.这里是鼠标鼠标鼠标鼠标鼠标鼠标.

更多相关视频

Assessment of the Metabolic Profile of Primary Leukemia Cells
06:21

Assessment of the Metabolic Profile of Primary Leukemia Cells

Published on: November 21, 2018

10.6K
Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
07:49

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

2.6K

相关实验视频

Last Updated: Sep 11, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

266
Assessment of the Metabolic Profile of Primary Leukemia Cells
06:21

Assessment of the Metabolic Profile of Primary Leukemia Cells

Published on: November 21, 2018

10.6K
Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
07:49

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

2.6K

科学领域:

  • 在瘤学瘤学.
  • 癌症新陈代谢 癌症新陈代谢
  • 分子生物学分子生物学

背景情况:

  • 蛋白质氨酸甲基转移酶1 (PRMT1) 在癌症中经常过度表达,与患者生存率差相关.
  • 急性巨核细胞白血病 (AMKL) 是急性髓性白血病的一个亚型,具有特定的分子驱动因素.
  • 白血病细胞系内PRMT1表达的异质性表明,不同的亚种群可能会推动疾病的进展.

研究的目的:

  • 研究PRMT1在AMKL病变发生中的作用及其对细胞代谢的影响.
  • 在临床前AMKL模型中评估PRMT1抑制的治疗潜力.
  • 阐明PRMT1在白血病细胞中调节的代谢途径.

主要方法:

  • 使用了一种具有异质Prmt1表达的小鼠AMKL细胞系 (6133).
  • 使用PRMT1抑制剂 (MS023) 进行治疗干预.
  • 进行海马分析以评估细胞呼吸和糖解.
  • 进行了代谢和流动细胞计分析,以评估脂质代谢.
  • 给了2-deoxy-D-glucose并进行了基因救援实验.

主要成果:

  • 在AMKL细胞亚群中高PRMT1表达对于体内白血病的发展至关重要.
  • 通过MS023有效治疗PRMT1驱动的AMKL来抑制PRMT1.
  • PRMT1上调糖解 (增加细胞外酸化率,葡萄糖消耗,乳酸生产) 和下调脂肪酸氧化 (减少氧气消耗率,减少CPT1A表达).
  • PRMT1促进了细胞内脂质的积累.
  • 葡萄糖模拟治疗延迟了AMKL的进展并诱导了分化;Cpt1a再表达挽救了扩散.

结论:

  • 通过增强糖解和抑制脂肪酸氧化,PRMT1促进AMKL的扩散.
  • 向PRMT1或葡萄糖代谢是AMKL的一个有前途的治疗策略.